Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027417 · ClinicalTrials.gov registry record · Phase 3
Study of Triostat in Infants During Heart Surgery
A Phase 3 study, sponsored by Michael Portman.
- Completed
- Registry status
- Phase 3
- Development phase
- 195
- Enrollment target
NCT00027417: Completed Phase 3 study, sponsored by Michael Portman.
NCT00027417 is a Phase 3 study that has completed, run by Michael Portman. The registered enrollment target is 195 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00027417, a Phase 3 study, has completed, sponsored by Michael Portman.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 195 participants
- Enrollment target
Study Summary
This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery.
Primary Outcome
Reducing the length of ventilatory support minimizes other postoperative complications, which can contribute to morbidity.
Interventions
- DRUG Liothyronine sodium/triiodothyronine
- PROCEDURE Cardiopulmonary bypass and cardiac surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2001-04 |
| Est. Completion | 2007-08 |
| Phase | Phase 3 |
What the finished NCT00027417 record still lists
NCT00027417 is an interventional study that assigns participants to a tested intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Liothyronine sodium/triiodothyronine is the first listed.
NCT00027417 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00027417 about?
NCT00027417 is a clinical study titled "Study of Triostat in Infants During Heart Surgery". This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery.
What is the current status of trial NCT00027417?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 195 participants. The study started on 2001-04. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00027417?
The interventions under investigation include: Liothyronine sodium/triiodothyronine (DRUG), Cardiopulmonary bypass and cardiac surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00027417?
This trial is sponsored by Michael Portman, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00027417's enrollment target sits among peer trials
195 1393rd of 2000 higher than 606 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276922 · 195 participants · NA
Creative Arts Program to Reduce Burnout in Healthcare Professionals
- NCT04829357 · 195 participants
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
- NCT05054738 · 195 participants · NA
CRP and S&A for Inpatient Veterans
- NCT05561595 · 195 participants · NA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia